NCT05364580View on ClinicalTrials.gov

The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines

PHASE3CompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

June 20, 2023

Study Completion Date

October 6, 2023

Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL

PROTOXIN

Botulinum toxin Type A

BIOLOGICAL

Botox®

Botulinum toxin Type A

Trial Locations (5)

Unknown

Kyung Hee University Hospital, Seoul

Chung-Ang University Hospital, Seoul

Konkuk University Hospital, Seoul

Nowon Eulji Medical Center, Seoul

Pusan National University Hospital, Pusan

All Listed Sponsors
lead

Protox Inc.

INDUSTRY